Cargando…

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers

BACKGROUND: Leukocyte telomere length (LTL) has been shown to predict Alzheimer’s disease (AD), albeit inconsistently. Failing to account for the competing risks between AD, other dementia types, and mortality, can be an explanation for the inconsistent findings in previous time-to-event analyses. F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hackenhaar, Fernanda Schäfer, Josefsson, Maria, Adolfsson, Annelie Nordin, Landfors, Mattias, Kauppi, Karolina, Hultdin, Magnus, Adolfsson, Rolf, Degerman, Sofie, Pudas, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283833/ https://www.ncbi.nlm.nih.gov/pubmed/34266503 http://dx.doi.org/10.1186/s13195-021-00871-y

Ejemplares similares

Short Leukocyte Telomeres, But Not Telomere Attrition Rates, Predict Memory Decline in the 20-Year Longitudinal Betula Study
por: Pudas, Sara, et al.
Publicado: (2020)

Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer’s Disease
por: Schäfer Hackenhaar, Fernanda, et al.
Publicado: (2023)

Effects of polygenic risk for Alzheimer’s disease on rate of cognitive decline in normal aging
por: Kauppi, Karolina, et al.
Publicado: (2020)

DNA methylation variations and epigenetic aging in telomere biology disorders
por: Carlund, Olivia, et al.
Publicado: (2023)

Longer Leukocyte Telomere Length Is Associated with Smaller Hippocampal Volume among Non-Demented APOE ε3/ε3 Subjects
por: Wikgren, Mikael, et al.
Publicado: (2012)

Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism
por: Degerman, Sofie, et al.
Publicado: (2014)

Hematopoietic cellular aging is not accelerated during the first 2 years of life in children born preterm
por: Henckel, Ewa, et al.
Publicado: (2020)

APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
por: Håglin, Sofia, et al.
Publicado: (2023)

Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals
por: Koch, Elise, et al.
Publicado: (2021)

APOE-ɛ4 effects on longitudinal decline in olfactory and non-olfactory cognitive abilities in middle-aged and old adults
por: Josefsson, Maria, et al.
Publicado: (2017)

Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma
por: Andersson-Evelönn, Emma, et al.
Publicado: (2020)

An integrated transcriptome analysis in T‐cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression
por: Haider, Zahra, et al.
Publicado: (2018)

DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma
por: Haider, Zahra, et al.
Publicado: (2020)

Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer’s Disease and Longitudinal Change in Hippocampus Function
por: Salami, Alireza, et al.
Publicado: (2022)

Loneliness Increases the Risk of All-Cause Dementia and Alzheimer’s Disease
por: Sundström, Anna, et al.
Publicado: (2020)

A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2021)

Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
por: Sun, Yu, et al.
Publicado: (2019)

Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
por: Walker, Rosie M., et al.
Publicado: (2021)

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
por: Zokaei, Nahid, et al.
Publicado: (2017)

Family Health Conversations Conducted by Telephone in Heart Failure Nursing Care: A Feasibility Study
por: Gusdal, Annelie K., et al.
Publicado: (2018)

Longitudinal association between hippocampus atrophy and episodic‐memory decline in non‐demented APOE ε4 carriers
por: Gorbach, Tetiana, et al.
Publicado: (2020)

Registered Nurses’ Perceptions about the Situation of Family Caregivers to Patients with Heart Failure - A Focus Group Interview Study
por: Gusdal, Annelie K., et al.
Publicado: (2016)

Differences in resting-state brain networks and gray matter between APOE ε2 and APOE ε4 carriers in non-dementia elderly
por: Wang, Zhiyuan, et al.
Publicado: (2023)

Traffic-Related Air Pollution and Dementia Incidence in Northern Sweden: A Longitudinal Study
por: Oudin, Anna, et al.
Publicado: (2015)

Bioenergetic and inflammatory systemic phenotypes in Alzheimer’s disease APOE ε4‐carriers
por: Wilkins, Heather M., et al.
Publicado: (2021)

Elevated plasma neurofilament light in aging reflects brain white‐matter alterations but does not predict cognitive decline or Alzheimer's disease
por: Nyberg, Lars, et al.
Publicado: (2020)

A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer’s Disease
por: Jiang, Shan, et al.
Publicado: (2016)

DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
por: Borssén, Magnus, et al.
Publicado: (2018)

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)

Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers
por: Martiskainen, Henna, et al.
Publicado: (2018)

Short-term memory advantage for brief durations in human APOE ε4 carriers
por: Zokaei, Nahid, et al.
Publicado: (2020)

Superior short-term memory in APOE ε2 carriers across the age range
por: Zokaei, Nahid, et al.
Publicado: (2021)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
por: Hou, Min, et al.
Publicado: (2021)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)

Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score
por: Ebenau, Jarith L., et al.
Publicado: (2021)

The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
por: Wu, Dongpeng, et al.
Publicado: (2021)

Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife
por: Dounavi, Maria-Eleni, et al.
Publicado: (2023)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
por: Evelönn, Emma Andersson, et al.
Publicado: (2019)

PM(2.5) and Dementia in a Low Exposure Setting: The Influence of Odor Identification Ability and APOE
por: Andersson, John, et al.
Publicado: (2023)

Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients
por: Wilkins, Heather M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e5dnvds0lupask53tl5q6nac9o